Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Henno P et al. - Pulmonary vascular dysfunction is frequent in end-stage CF, involving the NF-kB pathway and that of ET-1 through its ET-A receptors. These data leave a conceptuable place to ET-A blockers and to isoflavones in the management of the devastating vascular complication of chronic obstructive respiratory diseases such as CF.

Related Articles

Diabetes as a Determinant of Mortality in Cystic Fibrosis
Diabetes Care, 11/20/09    Relevance Score: 69%

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09    Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09    Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09    Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 69%

Today in Cystic Fibrosis...keeping you current

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures
Lung Cellular and Molecular Physiology, 12/16/09

Influenza Associated Cystic Fibrosis Pulmonary Exacerbations
Chest, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address